世界のヒト免疫不全ウイルス (HIV) 治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5787 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ヒト免疫不全ウイルス (HIV) 治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NRTI、NNRTI、侵入＆融合阻害剤、プロテアーゼ阻害剤、インテグラーゼ阻害剤、補助受容体拮抗剤）、用途別市場規模（病院、診療所、研究室）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ヒト免疫不全ウイルス (HIV) 治療薬の市場動向 ・企業の競争状況、市場シェア ・ヒト免疫不全ウイルス (HIV) 治療薬の種類別市場規模と予測2016-2027（NRTI、NNRTI、侵入＆融合阻害剤、プロテアーゼ阻害剤、インテグラーゼ阻害剤、補助受容体拮抗剤） ・ヒト免疫不全ウイルス (HIV) 治療薬の用途別市場規模と予測2016-2027（病院、診療所、研究室） ・ヒト免疫不全ウイルス (HIV) 治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ヒト免疫不全ウイルス (HIV) 治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト免疫不全ウイルス (HIV) 治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト免疫不全ウイルス (HIV) 治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト免疫不全ウイルス (HIV) 治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ViiV Healthcare、Mylan、AbbVie、Merck & Co., Inc.、Bristol-Myers Squibb Company、Boehringer Ingelheim GmbH、Genentech, Inc.、Cipla, Inc.、Boehringer Ingelheim GmbH、Genentech, Inc.） ・結論

Market Analysis and Insights: Global Human Immunodeficiency Virus (HIV) Therapeutics Market
The global Human Immunodeficiency Virus (HIV) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Immunodeficiency Virus (HIV) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Immunodeficiency Virus (HIV) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Immunodeficiency Virus (HIV) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Immunodeficiency Virus (HIV) Therapeutics market.

Global Human Immunodeficiency Virus (HIV) Therapeutics Scope and Market Size
Human Immunodeficiency Virus (HIV) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Immunodeficiency Virus (HIV) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NRTIs
NNRTIs
Entry and Fusion Inhibitors
Protease Inhibitors
Integrase Inhibitors
Coreceptor Antagonists

Segment by Application
Hospitals
Clinics
Labs

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ViiV Healthcare
Mylan
AbbVie
Merck & Co., Inc.
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
Genentech, Inc.
Cipla, Inc.
Boehringer Ingelheim GmbH
Genentech, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NRTIs
1.2.3 NNRTIs
1.2.4 Entry and Fusion Inhibitors
1.2.5 Protease Inhibitors
1.2.6 Integrase Inhibitors
1.2.7 Coreceptor Antagonists
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Perspective (2016-2027)
2.2 Human Immunodeficiency Virus (HIV) Therapeutics Growth Trends by Regions
2.2.1 Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Human Immunodeficiency Virus (HIV) Therapeutics Industry Dynamic
2.3.1 Human Immunodeficiency Virus (HIV) Therapeutics Market Trends
2.3.2 Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers
2.3.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges
2.3.4 Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV) Therapeutics Revenue
3.4 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2020
3.5 Human Immunodeficiency Virus (HIV) Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Immunodeficiency Virus (HIV) Therapeutics Product Solution and Service
3.7 Date of Enter into Human Immunodeficiency Virus (HIV) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2016-2027)
6.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
6.2.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2027)
6.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
6.3.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2027)
6.4 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
6.4.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2016-2027)
7.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
7.2.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
7.3.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
7.4.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2016-2027)
9.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
9.2.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
9.3.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
9.4.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Details
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.1.4 ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.1.5 ViiV Healthcare Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.2.4 Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.3.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.4.4 Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Company Details
11.6.2 Boehringer Ingelheim GmbH Business Overview
11.6.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.6.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.6.5 Boehringer Ingelheim GmbH Recent Development
11.7 Genentech, Inc.
11.7.1 Genentech, Inc. Company Details
11.7.2 Genentech, Inc. Business Overview
11.7.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.7.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.7.5 Genentech, Inc. Recent Development
11.8 Cipla, Inc.
11.8.1 Cipla, Inc. Company Details
11.8.2 Cipla, Inc. Business Overview
11.8.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.8.4 Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.8.5 Cipla, Inc. Recent Development
11.9 Boehringer Ingelheim GmbH
11.9.1 Boehringer Ingelheim GmbH Company Details
11.9.2 Boehringer Ingelheim GmbH Business Overview
11.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.9.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.9.5 Boehringer Ingelheim GmbH Recent Development
11.10 Genentech, Inc.
11.10.1 Genentech, Inc. Company Details
11.10.2 Genentech, Inc. Business Overview
11.10.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction
11.10.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
11.10.5 Genentech, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NRTIs
Table 3. Key Players of NNRTIs
Table 4. Key Players of Entry and Fusion Inhibitors
Table 5. Key Players of Protease Inhibitors
Table 6. Key Players of Integrase Inhibitors
Table 7. Key Players of Coreceptor Antagonists
Table 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Regions (2022-2027)
Table 14. Human Immunodeficiency Virus (HIV) Therapeutics Market Trends
Table 15. Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers
Table 16. Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges
Table 17. Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints
Table 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2020)
Table 21. Ranking of Global Top Human Immunodeficiency Virus (HIV) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Human Immunodeficiency Virus (HIV) Therapeutics Product Solution and Service
Table 25. Date of Enter into Human Immunodeficiency Virus (HIV) Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. ViiV Healthcare Company Details
Table 66. ViiV Healthcare Business Overview
Table 67. ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 68. ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 69. ViiV Healthcare Recent Development
Table 70. Mylan Company Details
Table 71. Mylan Business Overview
Table 72. Mylan Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 73. Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Mylan Recent Development
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 78. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 79. AbbVie Recent Development
Table 80. Merck & Co., Inc. Company Details
Table 81. Merck & Co., Inc. Business Overview
Table 82. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 83. Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Merck & Co., Inc. Recent Development
Table 85. Bristol-Myers Squibb Company Company Details
Table 86. Bristol-Myers Squibb Company Business Overview
Table 87. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 88. Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Bristol-Myers Squibb Company Recent Development
Table 90. Boehringer Ingelheim GmbH Company Details
Table 91. Boehringer Ingelheim GmbH Business Overview
Table 92. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 93. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Boehringer Ingelheim GmbH Recent Development
Table 95. Genentech, Inc. Company Details
Table 96. Genentech, Inc. Business Overview
Table 97. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 98. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Genentech, Inc. Recent Development
Table 100. Cipla, Inc. Company Details
Table 101. Cipla, Inc. Business Overview
Table 102. Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Cipla, Inc. Recent Development
Table 104. Boehringer Ingelheim GmbH Company Details
Table 105. Boehringer Ingelheim GmbH Business Overview
Table 106. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 107. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Boehringer Ingelheim GmbH Recent Development
Table 109. Genentech, Inc. Company Details
Table 110. Genentech, Inc. Business Overview
Table 111. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product
Table 112. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Genentech, Inc. Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. NRTIs Features
Figure 3. NNRTIs Features
Figure 4. Entry and Fusion Inhibitors Features
Figure 5. Protease Inhibitors Features
Figure 6. Integrase Inhibitors Features
Figure 7. Coreceptor Antagonists Features
Figure 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Labs Case Studies
Figure 12. Human Immunodeficiency Virus (HIV) Therapeutics Report Years Considered
Figure 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players in 2020
Figure 18. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2020
Figure 20. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2016-2027)
Figure 42. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. ViiV Healthcare Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 66. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 67. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 68. Cipla, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 69. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 70. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---